The Pharmacogenomics Market is projected to reach $19.5 billion by 2031, at a CAGR of 8.9% during the forecast period 2024โ2031. The pharmacogenomics market includes consumables, instruments, and software & services. The pharmacogenomics market is driven by the growing therapeutic applications of pharmacogenomic biomarkers, the increasing adoption of personalized medicines, the rising geriatric population and chronic disease prevalence, and the U.S. FDAโs and EMAโs recommendations for using pharmacogenomic data in drug discovery & development.
read more..